Polymerase Chain Reaction on Respiratory Tract Specimens of Immunocompromised Patients to Diagnose Pneumocystis Pneumonia: A Systematic Review and Meta-analysis
Clinical Infectious Diseases · 19.07.2024 · 79 (1) · 161-168
DOI: 10.1093/cid/ciae239 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Infectious Diseases, online erschienen am 11.06.2024. Verfasst von Lottie Brown und 16 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Infection and Immunity, St George's University and St Georges University Hospitals NHS Foundation Trust, London, United Kingdom. Hauptthemen laut MEDLINE: Pneumonia, Pneumocystis, Immunocompromised Host, Sensitivity and Specificity, Bronchoalveolar Lavage Fluid. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute for Health and Care Research Manchester Biomedical Research Centre, National Institute for Health, Care Research Manchester Biomedical Research Centre.
Abstract (Originalsprache)
Background
This meta-analysis examines the comparative diagnostic performance of polymerase chain reaction (PCR) for the diagnosis of Pneumocystis pneumonia (PCP) on different respiratory tract samples, in both human immunodeficiency virus (HIV) and non-HIV populations.
Methods
A total of 55 articles met inclusion criteria, including 11 434 PCR assays on respiratory specimens from 7835 patients at risk of PCP. QUADAS-2 tool indicated low risk of bias across all studies. Using a bivariate and random-effects meta-regression analysis, the diagnostic performance of PCR against the European Organisation for Research and Treatment of Cancer–Mycoses Study Group definition of proven PCP was examined.
Results
Quantitative PCR (qPCR) on bronchoalveolar lavage fluid provided the highest pooled sensitivity of 98.7% (95% confidence interval [CI], 96.8%–99.5%), adequate specificity of 89.3% (95% CI, 84.4%–92.7%), negative likelihood ratio (LR−) of 0.014, and positive likelihood ratio (LR+) of 9.19. qPCR on induced sputum provided similarly high sensitivity of 99.0% (95% CI, 94.4%–99.3%) but a reduced specificity of 81.5% (95% CI, 72.1%–88.3%), LR− of 0.024, and LR+ of 5.30. qPCR on upper respiratory tract samples provided lower sensitivity of 89.2% (95% CI, 71.0%–96.5%), high specificity of 90.5% (95% CI, 80.9%–95.5%), LR− of 0.120, and LR+ of 9.34. There was no significant difference in sensitivity and specificity of PCR according to HIV status of patients.
Conclusions
On deeper respiratory tract specimens, PCR negativity can be used to confidently exclude PCP, but PCR positivity will likely require clinical interpretation to distinguish between colonization and active infection, partially dependent on the strength of the PCR signal (indicative of fungal burden), the specimen type, and patient population tested.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Infection and Immunity, St George's University and St Georges University Hospitals NHS Foundation Trust, London, United Kingdom.
- Mycology Reference Centre Manchester and Department of Infectious Diseases, Manchester Academic Health Science Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust and Division of Evolution, Infectio…
- Department of Infectious, Parasitic and Immune-Mediated Diseases, Instituto Superiore Di Sanita, Rome, Italy.
- Unité de Mycologie Moléculaire, Institut Pasteur, Paris, France.
- Department of Infection, Immunity and Biochemistry and School of Medicine, University of Cardiff, United Kingdom.
- Université Paris Cité, Parasitology-Mycology Laboratory, Hôpital Saint-Louis, APHP, Paris, France.
ORCID-Profile: Lottie Brown, Riina Rautemaa-Richardson, Carlo Mengoli, Alexandre Alanio, Rosemary A Barnes, Stéphane Bretagne, Sharon C A Chen, J Peter Donnelly, Werner J Heinz, Brian Jones, Lena Klingspor, Thomas R Rogers, P Lewis White, Mario Cruciani
Förderung
- National Institute for Health and Care Research Manchester Biomedical Research Centre
- National Institute for Health
- Care Research Manchester Biomedical Research Centre
Zitieren
APA
Brown, L., Rautemaa-Richardson, R., Mengoli, C., Alanio, A., Barnes, R. A., Bretagne, S., Chen, S. C. A., Cordonnier, C., Donnelly, J. P., Heinz, W. J., Jones, B., Klingspor, L., Loeffler, J., Rogers, T. R., Rowbotham, E., White, P. L., & Cruciani, M. (2024). Polymerase Chain Reaction on Respiratory Tract Specimens of Immunocompromised Patients to Diagnose Pneumocystis Pneumonia: A Systematic Review and Meta-analysis. Clinical Infectious Diseases, 79(1), 161-168. https://doi.org/10.1093/cid/ciae239
Vancouver
Brown L, Rautemaa-Richardson R, Mengoli C, Alanio A, Barnes RA, Bretagne S, et al. Polymerase Chain Reaction on Respiratory Tract Specimens of Immunocompromised Patients to Diagnose Pneumocystis Pneumonia: A Systematic Review and Meta-analysis. Clinical Infectious Diseases. 2024;79(1):161-168. doi:10.1093/cid/ciae239
BibTeX
@article{Brown2024,
author = {Brown, Lottie and Rautemaa-Richardson, Riina and Mengoli, Carlo and Alanio, Alexandre and Barnes, Rosemary A and Bretagne, Stéphane and Chen, Sharon C A and Cordonnier, Catherine and Donnelly, J Peter and Heinz, Werner J and Jones, Brian and Klingspor, Lena and Loeffler, Juergen and Rogers, Thomas R and Rowbotham, Eleanor and White, P Lewis and Cruciani, Mario},
title = {Polymerase Chain Reaction on Respiratory Tract Specimens of Immunocompromised Patients to Diagnose Pneumocystis Pneumonia: A Systematic Review and Meta-analysis},
journal = {Clinical Infectious Diseases},
year = {2024},
volume = {79},
number = {1},
pages = {161--168},
doi = {10.1093/cid/ciae239}
}
EUVIMED